mmuneresponses invaccinees.
o avoid potential severe adverse events caused by enhance
econtrolledandkeptataconstantlevel,forcommercialisation
timulatory components in a plant-derived vaccine may need t
lant-origin lipids/glycolipids in the vaccine formulation38. Thes
ellular immune responses, potentially as a direct effect of th
mmunity that predominantly facilitates Type 1 pro-inflammator
ttribute of plant-derived rHA is that it can stimulate innat
he circulating influenza viruses each season. A unique positiv
A component of the vaccine to reflect antigenic change i
accineproduction,whichtypicallyinvolvesupdatingatleaston
ystems34.Theunpredictable yieldcould adversely impacttimel
enome,hasbeenamajorchallengewithplant-basedexpressio
ue to nonspecific integration of transgene(s) into the hos
owever,inconsistencyintheexpressionlevelsoftargetproteins
iven at 15Âµg dose/strain in adults aged 18 to 64 years37
nfluenza vaccine (QIV; Fluarix Quadrivalent, GlaxoSmithKline
llness and influenza-like illness to a quadrivalent inactivate